FdaApplication
ANDA 205501
Identifiers
- fda_app_no: ANDA205501
Properties
| Property | Value |
|---|---|
| applicant_name | AMNEAL PHARMACEUTICALS OF NEW YORK LLC |
| application_type | ANDA |
| approval_date | 2015-07-13 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| TOBRAMYCIN | TOBRAMYCIN | 300MG/5ML | SOLUTION;INHALATION |
1 product